Company / SG&A Expense
Medtronic SG&A Expense History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$10.7B
FY2026
5-year range
$10.1B / $10.8B
FY2022-FY2026
Trend
+3.1%
vs FY2025
Sector context
#8 of 158
Health Care
What the data says
Among 158 Health Care companies, Medtronic is in the bottom 5% for sg&a expense. SG&A Expense remained relatively stable over the past 10 years, with values between $10.1B and $10.8B.
Based on SEC 10-K filings.
$10.7B in FY2026 with a 5-year CAGR of +0.6%. Top quartile in the Health Care sector.
Remained stable around $10.7B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- +0.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 158This company $10.7B Sector average $175.9B
▼
-93.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.6%, indicating consistent growth.
- In FY2026, sg&a expense increased 3.1% year-over-year.
- Ranks #8 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $10.7B | +3.1% |
| FY2025 | $10.4B | -4.0% |
| FY2024 | $10.8B | +6.9% |
| FY2023 | $10.1B | +0.4% |
| FY2022 | $10.1B | -3.0% |
| FY2021 | $10.4B | +2.7% |
| FY2020 | $10.1B | +0.4% |
| FY2019 | $10.1B | -3.0% |
| FY2018 | $10.4B | +1.8% |
| FY2017 | $10.2B | +2.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026